A F Auld

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials?
    Andrew F Auld
    Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, 30333, USA
    Trans R Soc Trop Med Hyg 110:432-44. 2016
  2. pmc Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality
    Andrew F Auld
    Division of Global HIV and TB, Center for Global Health, United States Centers for Disease Control and Prevention CDC, 1600 Clifton Road, Atlanta, GA, 30333, USA
    BMC Infect Dis 16:606. 2016
  3. pmc Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008
    Andrew F Auld
    Division of Global HIV AIDS DGHA, Center for Global Health CGH, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS ONE 8:e54665. 2013
  4. ncbi request reprint Piloting the use of personal digital assistants for tuberculosis and human immunodeficiency virus surveillance, Kenya, 2007
    A F Auld
    Care and Treatment Team, Global AIDS Program, National Center for HIV, Hepatitis, STD and TB Prevention, Global AIDS Program, US Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Int J Tuberc Lung Dis 14:1140-6. 2010
  5. pmc Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program
    Andrew F Auld
    Division of Global AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e18453. 2011

Detail Information

Publications5

  1. doi request reprint Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials?
    Andrew F Auld
    Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, 30333, USA
    Trans R Soc Trop Med Hyg 110:432-44. 2016
    ..So far as equipoise exists, future trials that address past limitations are needed to inform Xpert use in resource-limited settings. ..
  2. pmc Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality
    Andrew F Auld
    Division of Global HIV and TB, Center for Global Health, United States Centers for Disease Control and Prevention CDC, 1600 Clifton Road, Atlanta, GA, 30333, USA
    BMC Infect Dis 16:606. 2016
    ..Together, the strengthened ICF intervention and Xpert activation are referred to as the "Xpert package"...
  3. pmc Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008
    Andrew F Auld
    Division of Global HIV AIDS DGHA, Center for Global Health CGH, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS ONE 8:e54665. 2013
    ..Monitoring proportions of enrollees screened for TB, and incidence and determinants of TB during ART can help clinicians and program managers identify program improvement opportunities...
  4. ncbi request reprint Piloting the use of personal digital assistants for tuberculosis and human immunodeficiency virus surveillance, Kenya, 2007
    A F Auld
    Care and Treatment Team, Global AIDS Program, National Center for HIV, Hepatitis, STD and TB Prevention, Global AIDS Program, US Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Int J Tuberc Lung Dis 14:1140-6. 2010
    ..In 2007, Kenya piloted the use of personal digital assistants (PDAs) instead of paper registers to collect TB-HIV surveillance data from TB clinics...
  5. pmc Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program
    Andrew F Auld
    Division of Global AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e18453. 2011
    ..All ART patients were eligible for co-trimoxazole. ART program outcomes, and determinants of outcomes, have not yet been reported...